Re:Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients

Shawna M. Woollard, Georgette D. Kanmogne

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)355-356
Number of pages2
JournalDrug Design, Development and Therapy
Volume10
StatePublished - Jan 1 2016

Fingerprint

Cyclohexanes
HIV Fusion Inhibitors
Triazoles
HIV Infections
Prescriptions
HIV-1
Therapeutics
maraviroc
CCR5 Receptor Antagonists

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery

Cite this

@article{8730bf70e3344e7bad0c966a3c1cbfc5,
title = "Re:Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-na{\"i}ve patients",
author = "Woollard, {Shawna M.} and Kanmogne, {Georgette D.}",
year = "2016",
month = "1",
day = "1",
language = "English (US)",
volume = "10",
pages = "355--356",
journal = "Drug Design, Development and Therapy",
issn = "1177-8881",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Re:Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients

AU - Woollard, Shawna M.

AU - Kanmogne, Georgette D.

PY - 2016/1/1

Y1 - 2016/1/1

UR - http://www.scopus.com/inward/record.url?scp=84955165053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955165053&partnerID=8YFLogxK

M3 - Article

C2 - 27104225

AN - SCOPUS:84955165053

VL - 10

SP - 355

EP - 356

JO - Drug Design, Development and Therapy

JF - Drug Design, Development and Therapy

SN - 1177-8881

ER -